Von Willebrand Factor as a New Noninvasive Predictor of Clinically Significant Portal Hypertension and Mortality in Liver Cirrhosis

被引:0
|
作者
Ferlitsch, Monika
Reiberger, Thomas
Hoke, Matthias
Salzl, Petra
Ulbrich, Gregor
Payer, Berit A.
Trauner, Michael H.
Peck-Radosavljevic, Markus
Ferlitsch, Arnulf
机构
关键词
D O I
10.1053/j.gastro.2012.07.082
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:E26 / E26
页数:1
相关论文
共 50 条
  • [21] Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Liver Disease: Whom and How to Screen?
    Sharma, Sanchit
    Agarwal, Samagra
    Anand, Abhinav
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (05): : 1096 - 1097
  • [22] Enhanced processing of von Willebrand factor reflects disease severity and discriminates severe portal hypertension in cirrhosis
    Langholm, Lasse L.
    Manon-Jensen, Tina
    Karsdal, Morten A.
    Bendtsen, Flemming
    Leeming, Diana J.
    Moller, Soren
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (08) : 1040 - 1048
  • [23] Altered von Willebrand Factor and ADAMTS13 Levels in Children With Cirrhosis and Extrahepatic Portal Hypertension
    Islek, Ali
    Ilhan, Derya
    Ozturk, Nurinnisa
    Guven, Burcu
    Sag, Elif
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (07) : E951 - E956
  • [24] Noninvasive assessment of portal hypertension in cirrhosis: Liver stiffness and beyond
    Stefanescu, Horia
    Procopet, Bogdan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (45) : 16811 - 16819
  • [25] Noninvasive assessment of portal hypertension in cirrhosis:Liver stiffness and beyond
    Horia Stefanescu
    Bogdan Procopet
    World Journal of Gastroenterology, 2014, (45) : 16811 - 16819
  • [26] REPRODUCIBILITY OF LIVER STIFFNESS IN CIRRHOSIS CAN AFFECT ITS ACCURACY FOR CLINICALLY SIGNIFICANT PORTAL HYPERTENSION DIAGNOSIS
    Yepes, I.
    Rincon, D.
    Ripoll, C.
    Fernandez, A.
    Matilla, A.
    Catalina, M. V.
    Salcedo, M.
    Miranda, J.
    Clemente, G.
    Banares, R.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S259 - S259
  • [27] Patients With Signs of Advanced Liver Disease and Clinically Significant Portal Hypertension Do Not Necessarily Have Cirrhosis
    Rodrigues, Susana G.
    Montani, Matteo
    Guixe-Muntet, Sergi
    De Gottardi, Andrea
    Berzigotti, Annalisa
    Bosch, Jaime
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (10) : 2101 - +
  • [28] Limited diagnostic value of liver stiffness for clinically significant portal hypertension in HBV-related cirrhosis
    Mengmeng Zhang
    Xiaoxia Niu
    Di Zhao
    Ruping Qi
    Xuexin Qi
    Jinghui Dong
    Yuan Liu
    Xu Bai
    Qiang Yu
    Changchun Liu
    Jianming Cai
    Abdominal Radiology, 2022, 47 : 3712 - 3723
  • [29] Plasma Cyclic Guanosine Monophosphate Is a Promising Biomarker of Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis
    Sturm, Lukas
    Bettinger, Dominik
    Roth, Lisa
    Zoldan, Katharina
    Stolz, Laura
    Gahm, Chiara
    Huber, Jan Patrick
    Reincke, Marlene
    Kaeser, Rafael
    Boettler, Tobias
    Kreisel, Wolfgang
    Thimme, Robert
    Schultheiss, Michael
    FRONTIERS IN MEDICINE, 2022, 8
  • [30] A Machine Learning Approach to Liver Histological Evaluation Predicts Clinically Significant Portal Hypertension in NASH Cirrhosis
    Bosch, Jaime
    Chung, Chuhan
    Carrasco-Zevallos, Oscar M.
    Harrison, Stephen A.
    Abdelmalek, Manal F.
    Shiffman, Mitchell L.
    Rockey, Don C.
    Shanis, Zahil
    Juyal, Dinkar
    Pokkalla, Harsha
    Le, Quang Huy
    Resnick, Murray
    Montalto, Michael
    Beck, Andrew H.
    Wapinski, Ilan
    Han, Ling
    Jia, Catherine
    Goodman, Zachary
    Afdhal, Nezam
    Myers, Robert P.
    Sanyal, Arun J.
    HEPATOLOGY, 2021, 74 (06) : 3146 - 3160